Clinical Trial Update: Stereotactic Ablation Radiotherapy Combined With Sintilimab in Early Inoperable Synchronous Multiple Primary Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial investigating stereotactic ablation radiotherapy combined with sintilimab for early inoperable synchronous multiple primary lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Primary Lung Cancer

Drugs mentioned

• Sintilimab (sintilimab)

Snippet

Sponsor: The First Affiliated Hospital of Xiamen University | Conditions: Multiple Primary Lung Cancer | Phase 1, Phase 2 | Status: UNKNOWN